Staphylococcus Aureus Nasal Carriage: Role in Continuous Ambulatory Peritoneal Dialysis-Associated Infections

White A. , Smith J. Nasal reservoir as the source of extranasal staphylococci. Antimicrob Agents Chemother 1963; 3: 679–83.

White A. Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci. Antimicrob Agents Chemother 1963; 3: 667–70.

Calia F.M. , Wolinsky E. , Mortimer E.A. Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis. J Hyg (Land) 1969; 67: 49–57.

Reagan D.R. , Doebbeling B.N. , Pfaller M.A. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114: 101–6.

Watanakunakorn C. , Brandt J. , Durkin P. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am J Infect Control 1992; 20: 138–41.

Chow J.W. , Yu V.L. Staphylococcus aureus nasal carriage in hemodialysis patients: its role in infection and approaches to prophylaxis. Arch Intern Med 1989; 149: 1258–62.

Kirmani N. , Tuazon C.U. , Murray H.W. Staphylococcus aureus carriage rate of patients receiving longterm hemodialysis. Arch Intern Med 1978; 138: 1657–9.

Casewell M.W. , Hill R.L.R. The carrier state: Methicillin resistant Staphylococcus aureus. J Antimicrob Chemother 1986; 18(Suppl A): 1–12.

Henderson R.J. , Williams R.E.O. Nasal disinfection in prevention of post-operative staphylococcal infection of wounds. Br Med J 1961; 2: 330–3.

Williams R.E.O. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacterial Rev 1963; 27: 56–71.

McNeilll F. , Porter La , Green C.A. Staphylococcal infection in a surgical ward: A three-month study. Br Med J 1961; 2: 798–802.

Bassett H.F.M. , Ferguson W.G. , Hoffman E. Sources of staphylococcal infection in surgical wound sepsis. J Hyg (Land) 1963; 61: 83–94.

Williams R.E.O. , Jevons M.P. , Shooter R.A. Nasal staphylococci and sepsis in hospital patients. Br Med J 1959; 2: 658–62.

Holton D.L. , Nicolle L.E. , Diley D. Efficacy of mupirocin nasal ointment in eradicating Staphylococ cus aureus nasal carriage in chronic haemodialysis patients. J Hosp Infect 1991; 17: 133–7.

Boelaert J.R. , De Smedt R.A. , De Baere Y.A. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989; 4: 278–81.

Yu V.L. , Goetz A. , Wagener M. , Smith P.B. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315: 91–6.

Ena J. , Boelaert J.R. , Boyken L. Epidemiology of infections in nasal carriers of S. aureus on haemodialysis (HD). Proceedings of 31st ICAAC. Chicago: American Society for Microbiology, 1991.

Luzar M.A. Exit-site infection in continuous ambulatory peritoneal dialysis: A review. Perit Dial Int 1991; 11: 333–40.

Piraino B. , Bernardini J. , Sorkin M. A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10: 281–6.

Zimmerman S.W. , O'Brien M. , Wiedenhoeft F.A. Staphylococcus aureus peritoneal catheter-related infections: a cause of catheter loss and peritonitis. Perit Dial Int 1988; 8: 191–4.

Grefberg N. , Danielson B.G. , Nilsson P. Peritonitis in patients on continuous ambulatory peritoneal dialysis: A changing scene. Scand J Infect Dis 1984; 16: 187–93.

Peterson P.K. , Matzke G. , Keane W.F. Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1987; 9: 604–12.

Sesso R. , Draibe S. , Castelo A. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1989; 31: 264–8.

Davies S.J. , Ogg C.S. , Cameron J.S. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 61–4.

Kim D. , Tapson J , Wu G. Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1984; 30: 494–7.

Sewell C.M. , Clarridge J. , Lacke C. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 1982; 248: 1493–5.

Pignatari A. , Pfaller M. , Hollis R. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 1990; 28: 1898–902.

Luzar M.A. , Coles G.A. , Faller B. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322: 505–9.

Herwaldt L.A. , Boyken L.D. , Luzar M.A. Molecular epidemiology of Staphylococcus aureus isolated from patients on chronic ambulatory peritoneal dialysis (Abstract 18). Proceedings of 2nd annual meeting of the Society for Hospital Epidemiology of America. Baltimore, Maryland, 1992.

McAnally T.P. , Lewis M.R. , Brown D.R. Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother 1984; 25: 422–6.

Bryan C.S. , Wilson R.S. , Meade P. Topical antibiotic ointments for staphylococcal nasal carriers: Survey of current practices and comparison of bacitracin and vancomycin ointments. Infect Control 1980; 1: 153–6.

Wheat L.J. , Kohler R.B. , White A.L. Effect of rifampin on nasal carriers of coagulase-positive staphylococci. J Infect Dis 1981; 144–77.

Wheat L.J. , Kohler R.B. , Luft F.C. Long-term studies of the effect ofrifampin on nasal carriage of coagulase positive staphylococci. Rev Infect Dis 1983; 5(Suppl 3): S459–62.

Casewell M.W. , Hill R.L.R. Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)–a controlled trial. J Antimicrob Chemother 1986; 17: 365–72.

Hill R.L.R. , Duckworth G.J. , Casewell M.W. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988; 22: 377–84.

Scully B.E. , Briones F. , Gu J. Mupirocin treatment of nasal staphylococcal colonization. Arch Intern Med 1992; 152: 353–6.

Frank U. , Lenz W. , Damrath E. Nasal carriage of Staphylococcus aureus treated with topical mupirocin (pseudomonic acid) in a children's hospital. J Hosp Infect 1989; 13: 117–20.

Doebbeling B.N. , Reagan D.R. , Pfaller M.A. Longterm follow-up of short course intranasal mupirocin on the prevalence of S. aureus nasal and hand carriage. Proceedings of the 31st annual interscience conference on antimicrobial agents and chemotherapy. Chicago: American Society for Microbiology, 1991.

Doebbeling B.N. , Pfaller M.A. , Reagan D.R. Investigation of the epidemiology of S. aureus carriage. Interscience conference on antimicrobial agents and chemotherapy. Chicago: American Society for Microbiology, 1991.

Boelaert J.R. , VanLanduyt H.W. , Godard C.A. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteremias in haemodialysis. Nephrol Dial Transplant 1993; 8: 235–39.

Kavi J. , Andrews J.M. , Wise R. Mupriocin-resistant Staphylococcus aureus. Lancet 1987; 2: 1472.

Cookson B.D. Mupriocin resistance in staphylococci. J Antimicrob Chemother 1990; 25: 497–503.

Rahman M. , Noble W.C. , Cookson B. Transmissible mupirocin resistance in Staphylococcus aureus Epidemiol Infect 1989; 102: 261–70.

Dryden M.S. , McCann M. , Phillips I. Housewife peritonitis: Conjugal transfer of a pathogen. J Hosp Infect 1991; 17: 69–72.

Widmer A.F. , Doebbeling B.N. , Costigan M. Source of recolonization following elimination of Staphylococcus aureus nasal carriage from chronic carriers. Proceedings of the 32nd annual interscience conference on antimicrobial agents and chemotherapy. Anaheim: American Society for Microbiology, 1992.